Point and Counterpoint
Cox - 2 Inhibitors and Cardiovascular Risk
We defend our data and suggest caution
Debabrata Mukherjee, MD, Steven E. Nissen, MD and Eric J. Topol, MD
Cleveland Clinic Journal of Medicine November 2001, 68 (11) 963-964;
Debabrata Mukherjee
Assistant Professor, Division of Cardiology, University of Michigan Health System, Ann Arbor
Steven E. Nissen
Vice Chairman, Department of Cardiovascular Medicine, Director of Clinical Cardiology, The Cleveland Clinic
Eric J. Topol
Chairman, Department of Cardiovascular Medicine, The Cleveland Clinic

Article Information
vol. 68 no. 11 963-964
PubMed
Published By
Print ISSN
Online ISSN
Copyright & Usage
Copyright © 2001 The Cleveland Clinic Foundation. All Rights Reserved.
Cited By...
In this issue
Cleveland Clinic Journal of Medicine
Vol. 68, Issue 11
1 Nov 2001
Cox - 2 Inhibitors and Cardiovascular Risk
Debabrata Mukherjee, Steven E. Nissen, Eric J. Topol
Cleveland Clinic Journal of Medicine Nov 2001, 68 (11) 963-964;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.